Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.
Frontiers in Immunology 2025 David Qixiang Chen, José Adalberto Inzunza Domínguez, Juan Manuel Valle Uzeta et al. 3 citations
Multiple sclerosis (MS) is a debilitating neurodegenerative disease characterized by demyelination and neuronal loss. Traditional therapies often fail to halt disease progression or reverse neurological deficits. Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients...